FAQ
The frequency of your cervical cancer screening will depend upon your risk of developing cervical cancer.
There are 3 risk categories. If your result shows that you are:
- Low risk: you will be invited to rescreen in 5 years as long as you have no other symptoms and have no evidence of HPV in your sample.
- Intermediate risk: you will be invited to have another HPV test in 12months if you have tested positive for one of the cancer-causing HPV Types (excluding Types 16 and 18)
- High risk: if you have tested positive for either or both HPV Types 16 and 18, you will be referred to a specialist for further investigation.
The National Cancer Screening Register will send a reminder communication to inform you when you are due for your next cervical screen.
The process of collecting cells for the HPV test is simple. A health care professional will gently brush a small sample of cells from the lower end of the womb (cervix) during an internal examination of the vagina – in the same way a Pap smear was collected.
Self collection for HPV testing is an option for many patients now. Please discuss this with your healthcare provider if you are interested.
The sample is then sent to our laboratory where it is tested. Your doctor will be notified of the results.
Please note: HPV testing is NOT performed on a blood sample.
The results of your cervical cancer screen will be sent to your doctor who will communicate with you appropriately.
If only minor changes show in your cells and a high risk HPV type is not evident, then you are at a lower risk of progressing to a precancerous or cancerous change in your cervix. In this instance, your doctor may recommend a follow up protocol, rather than further treatment. Cervical lesions, caused by HPV can almost always be easily treated. Your doctor will be able to discuss effective treatment options with you.
Remember that cervical cancer is a rare condition.Advances in laboratory testing have led to the prevention of many cases; with procedures such as the HPV test playing a role in reducing the incidence of cervical cancer.
Cervical screening requests that follow the national prescribed laboratory process will be bulk billed subject to Medicare guidelines and criteria. If a request for Cervical Cancer Screening is different to the Medicare guidelines and criteria, an out-of-pocket fee may apply.
Please discuss this with your doctor.